Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock suffered a major decline of -10.7% on 1/10/25. The shares closed at $6.40. Moreover, exceptionally high trading volume at 245% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -13.5% during the last week.
Current PriceTarget Research Rating
Iovance Biotherapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Iovance Biotherapeutics has a slightly negative Power Rating of 35 and a poor Appreciation Score of 18, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment